Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Solomon JP, Dell'Aquila M, Fadare O, Hasteh F. Her2/neu Status Determination in Breast Cancer: A Single Institutional Experience Using a Dual-Testing Approach With Immunohistochemistry and Fluorescence In Situ Hybridization. Am J Clin Pathol. 2017;147(4):432-437.

Magro CM, Momtahen S, Harp J. The distinctive histopathology of hydralazine-associated ANCA positive vasculitis: in vivo demonstration of NETosis. Eur J Dermatol. 2017;27(1):91-92.

Anelli V, Villefranc JA, Chhangawala S, Martinez-McFaline R, Riva E, Nguyen A, et al. Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression. Elife. 2017;6.

Beltran H, Wyatt AW, Chedgy EC, Donoghue A, Annala M, Warner EW, et al. Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy. Clin Cancer Res. 2017;23(22):6802-6811.

Morgenstern P, Pisapia D, Ramakrishna R. Calvarial Plasmacytoma Mimicking Meningioma as the Initial Presentation of Multiple Myeloma. Cureus. 2017;9(3):e1126.

Huang Y, Rajappa P, Hu W, Hoffman C, Cisse B, Kim J-, et al. A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma. J Clin Invest. 2017;127(5):1826-1838.

Van Besien K, Koshy N, Gergis U, Mayer S, Cushing M, Rennert H, et al. Haplo-cord transplant: HLA-matching determines graft dominance. Leuk Lymphoma. 2017;58(6):1512-1514.

Staunton L, Tonry C, Lis R, Espina V, Liotta L, Inzitari R, et al. Pathology-Driven Comprehensive Proteomic Profiling of the Prostate Cancer Tumor Microenvironment. Mol Cancer Res. 2017;15(3):281-293.

Szeto HH, Liu S, Soong Y, Seshan SV, Cohen-Gould L, Manichev V, et al. Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1 and IL-18 and Arrests CKD. J Am Soc Nephrol. 2017;28(5):1437-1449.

Posch F, Gebhart J, Rand JH, Koder S, Quehenberger P, Pengo V, et al. Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant. BMC Med. 2017;15(1):54.